...
首页> 外文期刊>Biochemical and Biophysical Research Communications >N-Acetyl-seryl-aspartyl-lysyl-proline inhibits DNA synthesis in human mesangial cells via up-regulation of cell cycle modulators
【24h】

N-Acetyl-seryl-aspartyl-lysyl-proline inhibits DNA synthesis in human mesangial cells via up-regulation of cell cycle modulators

机译:N-乙酰基-丝氨酰-天冬氨酰-赖氨酰-脯氨酸通过上调细胞周期调节剂抑制人系膜细胞的DNA合成

获取原文
获取原文并翻译 | 示例
           

摘要

N-Acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) was originally reported as a natural inhibitor of the proliferation of stem cells. To elucidate whether Ac-SDKP inhibits the proliferation of human mesangial cells, we examined the effect of Ac-SDKP on retal calf serum (FCS)- or platelet-derived growth factor (PDGF)-BB-induced DNA synthesis and a cell proliferation. Ac-SDKP inhibited PDGF-BB- or FCS-induced DNA synthesis without cellular toxicity. The protein expression of p53 and p27(kip1) was significantly increased by AcSDKP. Ac-SDKP also up-regulated the PDGF-BB-stimulated expression of p21(cip1) and suppressed PDGF-BB-induced cyclin D, expression. In p53 knock-out human mesangial cells made with small interference RNA, the protein expression of p21(cip1) and p27(kip1) was also decreased and the inhibitory effect of Ac-SDKP on mesangial proliferation was completely abolished. Ac-SDKP increased the stability of p53 protein as demonstrated by pulse-chase experiment. These results suggest that p53 is the key mediator of Ac-SDKP-induced inhibition of DNA synthesis through the up-regulation of cell cycle modulators, highlighting a potential effect of Ac-SDKP on various progressive renal diseases. (c) 2006 Elsevier Inc. All rights reserved.
机译:N-乙酰基-丝氨酰-天冬氨酰-赖氨酰-脯氨酸(Ac-SDKP)最初被报道为干细胞增殖的天然抑制剂。为了阐明Ac-SDKP是否抑制人系膜细胞的增殖,我们检查了Ac-SDKP对小牛血清(FCS)或血小板衍生的生长因子(PDGF)-BB诱导的DNA合成和细胞增殖的影响。 Ac-SDKP抑制PDGF-BB-或FCS诱导的DNA合成,而没有细胞毒性。 AcSDKP显着增加了p53和p27(kip1)的蛋白表达。 Ac-SDKP还可以上调PDGF-BB刺激的p21(cip1)表达,并抑制PDGF-BB诱导的cyclin D表达。在用小干扰RNA制备的p53基因敲除的人系膜细胞中,p21(cip1)和p27(kip1)的蛋白表达也降低,并且Ac-SDKP对系膜增殖的抑制作用被完全消除。 Ac-SDKP通过脉冲追逐实验证明了p53蛋白的稳定性。这些结果表明,p53是Ac-SDKP诱导的DNA合成抑制的关键介质,通过上调细胞周期调节剂来发挥作用,突显了Ac-SDKP对各种进行性肾脏疾病的潜在作用。 (c)2006 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号